Zydus Lifesciences stock rises after securing approval for Darunavir tablets
Zydus Lifesciences receives approval from USFDA for Darunavir Tablets in 600 mg and 800 mg strengths
Zydus Lifesciences receives approval from USFDA for Darunavir Tablets in 600 mg and 800 mg strengths